Business Description
Applied Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US03828A1016
Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 427.07 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 43.8 | |||||
| 3-Year EPS without NRI Growth Rate | 44.1 | |||||
| 3-Year FCF Growth Rate | 43.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.7 | |||||
| 9-Day RSI | 31.63 | |||||
| 14-Day RSI | 33.91 | |||||
| 6-1 Month Momentum % | 132.97 | |||||
| 12-1 Month Momentum % | 207.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | |||||
| Quick Ratio | 1.8 | |||||
| Cash Ratio | 1.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -55.7 | |||||
| Shareholder Yield % | -36.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 15675.47 | |||||
| Net Margin % | 40579.46 | |||||
| FCF Margin % | 14065.83 | |||||
| ROE % | -3152.71 | |||||
| ROA % | -297.87 | |||||
| ROIC % | -176.35 | |||||
| ROC (Joel Greenblatt) % | -11510.47 | |||||
| ROCE % | -1103.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 6.93 | |||||
| Price-to-Tangible-Book | 6.93 | |||||
| EV-to-EBIT | -4.28 | |||||
| EV-to-Forward-EBIT | -4.74 | |||||
| EV-to-EBITDA | -4.3 | |||||
| EV-to-Forward-EBITDA | -4.74 | |||||
| EV-to-Revenue | -671.01 | |||||
| EV-to-Forward-Revenue | 103.83 | |||||
| EV-to-FCF | -4.77 | |||||
| Price-to-Net-Current-Asset-Value | 6.92 | |||||
| Price-to-Net-Cash | 7.42 | |||||
| Earnings Yield (Greenblatt) % | -23.36 | |||||
| FCF Yield % | -14.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:APLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Applied Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.477 | ||
| EPS (TTM) ($) | -1.84 | ||
| Beta | 2.44 | ||
| Volatility % | 175.25 | ||
| 14-Day RSI | 33.91 | ||
| 14-Day ATR ($) | 0.302828 | ||
| 20-Day SMA ($) | 4.4225 | ||
| 12-1 Month Momentum % | 207.86 | ||
| 52-Week Range ($) | 1.18 - 9.39 | ||
| Shares Outstanding (Mil) | 114.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Applied Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Applied Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Applied Therapeutics Inc Frequently Asked Questions
What is Applied Therapeutics Inc(APLT)'s stock price today?
The current price of APLT is $4.08. The 52 week high of APLT is $9.39 and 52 week low is $1.18.
When is next earnings date of Applied Therapeutics Inc(APLT)?
The next earnings date of Applied Therapeutics Inc(APLT) is 2024-08-09 Est..
Does Applied Therapeutics Inc(APLT) pay dividends? If so, how much?
Applied Therapeutics Inc(APLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers